Concepedia

Tom Anbergen

TA

4

Publications

142

Citations

4

H-Index

2021

Active since

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

Eindhoven University of Technology

Icahn School of Medicine at Mount Sinai

University of Bonn

Tom Anbergen is an author at Radboud University Medical Center specializing in biomedical engineering, nanoparticles, and nanomedicine.

ORCID

Top concepts

Publications per year

2021–2025

4

Publications

4

Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells

David P. Schrijver, Rutger J. Röring, Jeroen Deckers et al. · Nature Biomedical Engineering · 2023 · 71 citations · Full text

Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors

Stijn R. J. Hofstraat, Tom Anbergen, Robby Zwolsman et al. · Nature Nanotechnology · 2025 · 33 citations · Full text

, , +8

Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy

Annelies C. Wauters, Jari F. Scheerstra, Mandy M. T. van Leent et al. · Nature Nanotechnology · 2024 · 22 citations · Full text

Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics

David P. Schrijver, Anne de Dreu, Stijn R. J. Hofstraat et al. · Advanced Therapeutics · 2021 · 16 citations · Full text

, , +18

Rows per page

1–4 of 4